Who we are
Accelerated biomedical research, new generations of cures, increased global sustainability by transitioning biology to engineering
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise.
bit.bio’s mission is coding cells for health. To do so, we apply the principles of computation to biology.
Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies.
To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy.
Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.
“At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future.”
Dr Mark Kotter, Founder & CEO